Find clinical trials for Multiple Myeloma in Indianapolis, IN

characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamethasone in participants with relapsed/refractory multiple...

A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...

Multiple Myeloma (MM) is a cancer of the blood's plasma cells ( blood cell). The cancer is typically found in the bones and bone ma...

of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...

given along with elranatamab in subjects with relapsed or refractory multiple myeloma.The first part of the study will evaluate dif...

B-cell maturation antigen (BCMA) is a target present on tumor cells in participants with multiple myeloma. Belantamab mafodotin (GS...

This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple...

The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to ide...

The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to id...

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the t...